Review
Gene Therapy (2009) 16, 1189–1201; doi:10.1038/gt.2009.81; published online 9 July 2009
Engineering ligand-responsive gene-control elements: lessons learned from natural riboswitches
K H Link1 and R R Breaker1,2,3
- 1Howard Hughes Medical Institute, Yale University, New Haven, CT, USA
- 2Department of Molecular, Cellular and Developmental Biology, Yale University, New Haven, CT, USA
- 3Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT, USA
Correspondence: Dr RR Breaker, Department of Molecular, Cellular and Developmental Biology, Yale University, PO Box 208103, New Haven, CT 06520-8103, USA. E-mail: ronald.breaker@yale.edu
Received 9 September 2008; Revised 4 March 2009; Accepted 5 March 2009; Published online 9 July 2009.
Abstract
In the last two decades, remarkable advances have been made in the development of technologies used to engineer new aptamers and ribozymes. This has encouraged interest among researchers who seek to create new types of gene-control systems that can be made to respond specifically to small-molecule signals. Validation of the fact that RNA molecules can exhibit the characteristics needed to serve as precision genetic switches has come from the discovery of numerous classes of natural ligand-sensing RNAs called riboswitches. Although a great deal of progress has been made toward engineering useful designer riboswitches, considerable advances are needed before the performance characteristics of these RNAs match those of protein systems that have been co-opted to regulate gene expression. In this review, we will evaluate the potential for engineered RNAs to regulate gene expression and lay out possible paths to designer riboswitches based on currently available technologies. Furthermore, we will discuss some technical advances that would empower RNA engineers who seek to make routine the production of designer riboswitches that can function in eukaryotes.
Keywords:
allosteric, aptamer, directed evolution, riboswitch, ribozyme, RNA switch
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
REVIEWS
Amyloid-β immunotherapy for Alzheimer's disease: the end of the beginning
Nature Reviews Neuroscience Perspective (01 Oct 2002)
Gene regulation by riboswitches
Nature Reviews Molecular Cell Biology Review (01 Jun 2004)
NEWS AND VIEWS
Nature Structural & Molecular Biology News and Views (01 Apr 2004)
Structural biology RNA switches function
Nature News and Views (29 Jun 2006)
RESEARCH
Computational design and experimental validation of oligonucleotide-sensing allosteric ribozymes
Nature Biotechnology Research (01 Nov 2005)
